Yoshihiro Horii - Concepedia

Author

Yoshihiro Horii

Kyoto Prefectural University of Medicine

Also Known As

Horii, Y., Y Horii, Y. HORII, Y. Horii, Yoshihiro HORII, Yoshihiro Horii

Publications

873

Citations

H-Index

Concepts

All Affiliations

Kyoto Prefectural University of Medicine Children's Research Hospital University Hospital Kyoto Prefectural University of Medicine Miyazaki Welfare Medical College Tokyo University of Agriculture and Technology

About

Yoshihiro Horii is an author at Kyoto Prefectural University of Medicine specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	602
2	Cell Biology	9	9	304
3	Natural Sciences	2	2	243
4	Biochemistry	1	1	53
5	Biomolecular Engineering	1	1	20

Yoshihiro Horii

Publications

836

Citations

H-Index

Page 1

	Year	Citations
A novel oncogene, ost, encodes a guanine nucleotide exchange factor that potentially links Rho and Rac signaling pathways. Yoshihiro Horii, John F. Beeler, Kazushige Sakaguchi, The EMBO Journal Redox SignalingExchange FactorSignal TransductionMolecular RegulationNatural Sciences	1994	190
Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Takafumi Sugimoto, T Kato, T. Sawada, PubMed Neuro-oncologyBrdu-treated Cell LinesTumor InnervationGliomaBrdu Treatment	1988	53
Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region Etsuo Naito, Michinori Ito, Ichiro Yokota, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Aldehyde DehydrogenaseBiochemistryGenetic DisorderNatural SciencesGenetics	2002	53
FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. Matthew V. Lorenzi, Yoshihiro Horii, Ryuya Yamanaka, Proceedings of the National Academy of Sciences PathologyCell ProliferationC-terminal FusionTumor BiologyDimer Formation	1996	45
Signal Transduction Pathways through TRK‐A and TRK‐B Receptors in Human Neuroblastoma Cells Tohru Sugimoto, Hiroshi Kuroda, Yoshihiro Horii, Japanese Journal of Cancer Research Tyrosine PhosphorylationSignal Transduction PathwaysSignal TransductionCell RegulationSignaling Pathway	2001	43
Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes Tohru Sugimoto, Hajime Hosoi, Yoshihiro Horii, International Journal of Cancer Smooth-muscle-cell PhenotypesPathologyCytoskeletonMrt Cell LineGlioma	1999	42
Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy Hiroshi Kuroda, Tohru Sugimoto, Kazumitsu Ueda, International Journal of Cancer	1991	40
Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Tohru Sugimoto, T. Sawada, Takafumi Matsumura, PubMed Tumor InnervationImmunologyBlood CellPathologyGlioma	1986	36
Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: Future aspects Tadashi Sawada, Tohru Sugimoto, Terufusa Tanaka, Medical and Pediatric Oncology	1987	35
Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. Takafumi Sugimoto, Yoshihiro Horii, T Hino, PubMed HistocompatibilityImmunogeneticsMedicineHla ImmunogeneticsImmunology	1989	34

Page 1